84 HR estradiol 0.00313 MG/HR Transdermal System [Vivelle]
RxNorm concept 1149634, branded drug (sbd). Prescribable name: Vivelle dot 0.075 MG/Day Twice Weekly Transdermal System.
- RxCUI
- 1149634
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/1149634 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
84 HR Vivelle 0.00313 MG/HR Transdermal System; Vivelle Dot 0.075 MG/24HR Twice Weekly Transdermal Patch; Vivelle dot 0.075 MG/Day Twice Weekly Transdermal System
Related concepts
- estradiol 0.00313 MG/HR (SCDC, consists of)
- estradiol 0.00313 MG/HR [Vivelle] (SBDC, consists of)
- Transdermal System (DF, has dose form)
- Vivelle (BN, has ingredient)
- 84 HR estradiol 0.00313 MG/HR Transdermal System (SCD, tradename of)
Linked data
NDCs
- 00078034542
- 00078034562
- 66758014858
- 66758014883
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 1149634 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/1149634 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 1149634. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.